Abstract | PURPOSE: METHODS: We identified all women with a primary endometrial cancer diagnosis between 2000 and 2012, who were alive one year after the diagnosis. Information on drug use, cause-specific mortality and potential confounders was obtained from nationwide health- and demographic registries. Cox regression models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between post-diagnostic non- aspirin NSAID use and endometrial cancer mortality. RESULTS: Among 6 694 endometrial cancer patients with a maximum follow-up of 13 years, 753 women died from endometrial cancer. Post-diagnostic non- aspirin NSAID use (≥ 1 filled prescription) was associated with an overall HR of 1.15 (95% CI; 0.97-1.36) for endometrial cancer mortality, with higher HRs for the highest intensity of use (HR; 1.40, 95% CI; 1.11-1.77) and largest cumulative amount (HR; 1.56, 95% CI; 1.14-2.14). CONCLUSION:
|
Authors | Cecilie Dyg Sperling, Freija Verdoodt, Gitte Lerche Aalborg, Christian Dehlendorff, Søren Friis, Susanne K Kjaer |
Journal | Cancer causes & control : CCC
(Cancer Causes Control)
Vol. 32
Issue 5
Pg. 515-523
(May 2021)
ISSN: 1573-7225 [Electronic] Netherlands |
PMID | 33620641
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Cohort Studies
- Endometrial Neoplasms
(mortality)
- Female
- Humans
- Middle Aged
- Proportional Hazards Models
- Registries
|